ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0606

Mechanism of Joint-Specific Homeobox D10 Regulation in Rheumatoid Arthritis Fibroblast-Like Synoviocytes

Hyeonjeong Lee1, Camilla Machado2, Deepa Hammaker3, Wei Wang4, David Boyle5 and Gary S. Firestein6, 1University of California San Diego, San Diego, CA, 2UCSD, San Diego, CA, 3UC San Diego, San Diego, CA, CA, 4University of California San Diego, San Diego, 5UCSD, La Jolla, CA, 6University of California, San Diego, San Diego, CA

Meeting: ACR Convergence 2022

Keywords: Epigenetics, Fibroblasts, Synovial, Gene Expression, rheumatoid arthritis, transcription factor

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) have joint-specific epigenetic and transcriptome profiles. This is particularly notable for homeobox (HOX) genes, which contribute to joint formation during embryogenesis. Furthermore, HOX gene expression patterns are often maintained in adulthood. In this study we analyzed joint-specific HOX gene regulation in hip- and knee-derived FLS. We then focused on HOXD10, which can regulate cell growth and migration, to understand the mechanism of its joint-specific expression and its potential role in FLS function.

Methods: RA FLS lines were obtained from hip and knee synovial tissues at arthroplasty and used from passages 5 through 8. qPCR was performed to assess gene expression, regulation, and mRNA half-life. HOXD10 was silenced by siRNA (~70% inhibition), and non-targeting siRNA was used as control. mRNA half-life was measured using actinomycin D to stop gene transcription. Cell migration was evaluated using an in vitro wound healing assay. Analysis of HOXD10 epigenetic marks was performed using our public ChIPseq data.

Results: Several HOX genes were differentially expressed in hip and knee join FLS. For example, HOXD10, HOXA13 and HOXD9 mRNA were more highly expressed in knee than hip FLS (85±20-fold, P=0.01; 3.8±1.8-fold, P=0.023; and 7.4±3.2-fold higher in knee, P=0.01, respectively). HOXA11 and HOXD3 mRNA expression were similar in FLS from the two joints. Knee FLS also showed higher expression of noncoding RNAs in HOX loci than hip FLS (HOXA11-AS 4.0±0.6-fold, P=0.003; and HOTAIR 1.7±0.1-fold higher in knee, P=0.02). Because differential HOXD10 expression was the greatest, we focused on this gene for subsequent studies. First, we confirmed that HOXD10 regulates cell migration in PDGF-stimulated FLS using siRNA knockdown (22±4.4% increase in hip FLS with HOXD10 deficiency, P=0.0006, and 15±6.3% increase in knee, P<0.0.05). To study HOXD10 regulation, we stimulated FLS with TNF and noted increased HOXD10 transcripts in both hip and knee FLS. The fold increase in gene expression was greater in hip than knee (7.2±2.2-fold induction in hip and 2.2±0.3-fold induction in knee; P=0.03 for hip vs. knee). However, knee HOXD10 expression remained higher than hip after TNF stimulation. To understand the mechanism of increased mRNA levels in knee FLS, we evaluated the transcript half-life. HOXD10 mRNA half-lives were similar in hip and knee FLS (t1/2 of 11 and 9 h, respectively, P=0.74). Evaluation of HOXD10 epigenetic marks in the promoter region showed increased H3K27ac and H3K4me3 peaks in knee FLS compared with hip FLS consistent with increased transcription in the former.

Conclusion: HOXD10 expression is constitutively higher in knee FLS than hip FLS and is highly induced by TNF. The mechanism of differential expression is mostly likely related gene transcription rather than mRNA degradation. Embryonic epigenetic imprinting might contribute to differences in joint-specific FLS behavior. HOX genes expression profiles might contribute to the patterns of joint involvement in arthritis and joint-specific responses to therapy.


Disclosures: H. Lee, None; C. Machado, None; D. Hammaker, None; W. Wang, None; D. Boyle, None; G. Firestein, Eli Lilly.

To cite this abstract in AMA style:

Lee H, Machado C, Hammaker D, Wang W, Boyle D, Firestein G. Mechanism of Joint-Specific Homeobox D10 Regulation in Rheumatoid Arthritis Fibroblast-Like Synoviocytes [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/mechanism-of-joint-specific-homeobox-d10-regulation-in-rheumatoid-arthritis-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mechanism-of-joint-specific-homeobox-d10-regulation-in-rheumatoid-arthritis-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology